Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-09-015424
Filing Date
2009-03-12
Accepted
2009-03-12 20:12:44
Documents
2
Period of Report
2009-03-10

Document Format Files

Seq Description Document Type Size
1 STOCK OPTION AWARD rrd237186.html 4  
1 STOCK OPTION AWARD rrd237186.xml 4 3807
2 POWER OF ATTORNEY rrd212738_240277.htm EX-24.1 3441
  Complete submission text file 0001181431-09-015424.txt   9111
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNAVAX TECHNOLOGIES CORP 2929 SEVENTH ST STE 100 BERKELEY CA 94710
Business Address 510-848-5100
COFFMAN ROBERT (Reporting) CIK: 0001278710 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 09677131